(IN BRIEF) Researchers at The Institute of Cancer Research, London, have found that the precise location of ATRX gene mutations plays a critical role in determining how neuroblastoma tumours behave and respond to treatment. Published in Neoplasia and supported by … Read the full press release
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged Arcobaleno Cancer Trust, ATRX gene, Cancer Research UK Clinician Scientist Fellowship, childhood cancer, differentiation therapy, Dr Federica Lorenzi, Dr Sally George, ICR, ICR Study Reveals How ATRX Mutation Location Influences Neuroblastoma Treatment Outcomes, Neoplasia, Neuroblastoma, New Research from The Institute of Cancer Research Advances Precision Approach to ATRX-Mutant Neuroblastoma, paediatric oncology, personalised medicine, Siobhans Superstar Legacy, stem cell modelling, The Institute of Cancer Research London, tumour genetics
(IN BRIEF) CERSI-PGx has launched a free eLearning portal to support the adoption of pharmacogenomics in routine clinical practice. Led by the University of Liverpool in partnership with the British Pharmacological Society and Queen Mary University of London, the platform … Read the full press release
Posted in Education, Healthcare, Internet & Online, Pharma & Biotech, Science, Technology, United Kingdom
Tagged British Pharmacological Society, CERSI PGx, eLearning portal, Faculty of Health and Life Sciences, genomic guided prescribing, genomic medicine, healthcare education Department of Pharmacology and Therapeutics, Innovate UK, Institute of Systems Molecular and Integrative Biology, Maria Tsakiroglou, New CERSI-PGx eLearning Platform Aims to Equip Healthcare Professionals for Genomic-Guided Prescribing, NHS genomics, personalised medicine, pharmacogenomics, Queen Mary University of London, regulatory science, Sir Munir Pirmohamed, Therapeutics Innovation, University of Liverpool
(IN BRIEF) Technical University of Munich researchers have found a way to boost oxidase biosensor accuracy from about 50% to 99% by using an alcohol oxidase oxygen scavenger that prevents signal loss, eliminating the need for calibration. The advancement enhances … Read the full press release
Posted in Agriculture, Education, Germany, Healthcare, Management, Pharma & Biotech, Science, Technology
Tagged agriculture nitrogen test, AI health data, AI-Data, alcohol oxidase, and Crop Analysis, biosensor accuracy, biotechnology, Breakthrough at TUM Boosts Oxidase Sensor Performance for Health, creatinine, glucose monitoring, Horizon Europe, Huijie Zhang, lactate, LiveSen-MAP, Mohamed Saadeldin, Nicolas Plumeré, oxidase biosensors, oxygen scavenger, personalised medicine, Science Advances, sustainability, Technical University of Munich, TUM, wearable diagnostics
(IN BRIEF) The EU‑funded AI4HF project is co‑designing, developing and evaluating a trustworthy AI tool to personalise heart failure care. Engaging over 200 stakeholders—including patients, clinicians and administrators—from Europe, South America and Africa, the project has held multiple workshops to … Read the full press release
Posted in Artificial Intelligence (AI), Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology
Tagged AI in healthcare, AI4HF, Amsterdam, Amsterdam UMC, Autumn 2025, Barcelona, bias mitigation, Brno, Clinical/Patient Working Groups, Dar es Salaam, ESC Digital Cardiology and AI Committee, European Heart Network, European Society of Cardiology, health literacy, heart failure, high‑dimensional data, Horizon Europe Framework, lifestyle recommendations, Lima, multi‑stakeholder workshops, partnership, personalised medicine, personalised risk assessment, Professor Folkert W. Asselbergs, shared decision-making, SHINE 2Europe, symptom interpretation, trustworthy AI
(IN BRIEF) The University of Glasgow is leading the PHOENIX Study, a landmark clinical trial investigating how genetic testing can personalise prescribing across NHS Scotland. Over 4,000 patients will be recruited across Greater Glasgow and Clyde to explore how DNA … Read the full press release
Posted in Business, Education, Financial, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Technology, United Kingdom
Tagged adverse drug reactions, Agena Bioscience, DNA testing, genetic testing, Katriona Brooksbank, Living Laboratory, medication safety, MyDNA, NHS Greater Glasgow and Clyde, NHS prescribing, personalised medicine, PGx, pharmacogenomics, PHOENIX Study, precision healthcare, Queen Elizabeth University Hospital, Sandosh Padmanabhan, University of Glasgow, West of Scotland Innovation Hub
(IN BRIEF) The largest study to date on testicular germ cell tumours (TGCTs) has revealed a potential link between testicular cancer risk and rare genetic variants affecting cellular movement and structure. Conducted by The Institute of Cancer Research, London, the … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer genetics, cell movement genes, Clare Turnbull, DNA mutations, European Urology Open Science, genetic risk, heritability in cancer, Movember Foundation, personalised medicine, rare genetic variants, testicular cancer, testicular germ cell tumours, TGCT, The Institute of Cancer Research, translational genomics, UK Biobank, whole-exome sequencing, Zeid Kuzbari
(IN BRIEF) CCRM Nordic is building a new ATMP production facility in GoCo Health Innovation City, Sweden, to support the development of next-generation gene, cell, and tissue-based therapies. AFRY will serve as engineering partner and project manager, leading the design, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged advanced therapy medicinal products, AFRY, ATMP, biotechnology innovation, CCRM Nordic, cell therapy, engineering partner, Fredrik Wessberg, future-proof lab design, gene therapy, GMP compliance, GoCo Health Innovation City, Martin Öman, Mölndal, partnership, personalised medicine, pharmaceutical manufacturing, project management, sustainability, sustainable pharmaceutical production, Sweden healthcare strategy
(IN BRIEF) The NextGen project, funded by the EU’s Horizon Europe program with €7.6 million, has commenced in Utrecht, the Netherlands. Led by a 21-member consortium including the European Society of Cardiology, the project aims to personalize therapies for patients … Read the full press release
Posted in Artificial Intelligence (AI), France, Healthcare, Netherlands, Society, Technology
Tagged AI, artificial-intelligence, cardiovascular disease, cardiovascular diseases, cardiovascular health, CVDs, ESC, European Society of Cardiology, EU’s Horizon Europe, genetics, personalised medicine, Professor Panos Deloukas, Professor Pim van der Harst, Queen Mary University of London, The NextGen project, therapies, University Medical Center Utrecht
(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Poland, Small Business, Technology
Tagged biomarker, biosensor system, blood glucose, blood glucose meters, Diabetes, endocrine disorders, glucose, glucose monitoring, home diagnostics, home tests, IQ Biozoom, lactate levels, medical technology, medical technology startup, medtech, metabolic disorders, non-invasive home diagnostics, non-invasive home testing, personalised medicine, saliva analysis, sports medicine, startup, VC Link fund
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?